ordinary shares of Modern Pharma Company Limited is a subsidiary of the Company, the Company, therefore, has a duty to disclose the transaction information of the Company to the Stock Exchange of Thailand

underwriting of TAKUNI and CCN securities, used nominee accounts to subscribe and receive allocated shares for patrons of such companies.Such conduct was in violation of the rule whereby securities selling or

subscribe and receive allocated shares for patrons of such companies.Such conduct was in violation of the rule whereby securities selling or allocation to directors, executives and related parties of the

at KTBST Securities and I V Global Securities Public Company in total of 8 securities accounts. In this regard, Ms. Uraiwan managed the financial transactions regarding thr trading of MBAX shares

Ref.No.IVL008/05/2018 11 th May 2018 President The Stock Exchange of Thailand Subject: Disclosure of Connected Transaction by IVL’s Subsidiaries The Board of Directors Meeting No. 4/2018 of Indorama Ventures

L-WAVE ENT 28/2020 1 July 2020 Subject: The acquisition of the shares in the Megawatt Company Limited To: President The Stock Exchange of Thailand Wave Entertainment Public Company Limited (the

M.D. 219/2019 November 15, 2019 Subject : Disclosure of the information connected transaction (Revised) To : President of the Stock of Exchange of Thailand Kang Yong Electric Public Company Limited

. Other derivatives liabilities 18. Provision 19. Other liabilities Total liabilities Shareholders’ equity 20. Share capital 20.1 Authorized share capital 20.2 Issued and paid-up share capital 21. Stock

Issued and paid-up share capital 21. Stock rights and warrants 22. Additional paid-in capital (discount on capital stock)) 23. Appraisal surplus 24. revaluation surplus (deficit) in investments) 25

capital 20.2 Issued and paid-up share capital 21. Stock rights and warrants 22. Additional paid-in capital (discount on capital stock)) 23. Appraisal surplus 24. revaluation surplus (deficit) in investments